Advertisement
Advertisement

HLVX

HLVX logo

HilleVax, Inc. Common Stock

1.70
USD
+0.05
+2.73%
Apr 17, 15:43 UTC -4
Closed
exchange

After-Market

1.69

-0.01
-0.29%

HilleVax, Inc. Common Stock Profile

About

HilleVax Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. Its initial program, HIL-214, is a virus-like particle based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. HilleVax Inc. is based in BOSTON.

Info & Links

CEO

Robert Hershberg

Headquarters

321 HARRISON AVE, SUITE 500
BOSTON, MA 02118, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.hillevax.com

Auditor

Ernst & Young LLP

Share holders

27

Employees

14

HilleVax, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

84.74M

Enterprise Value

-69.73M

Enterprise Value/EBITDA(ttm)

0.45

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.51

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-67.27%

Return on Invested Capital(ttm)

-73.55%

Return on Assets(ttm)

-51.99%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-156.16M

Net Income Available to Common(ttm)

-147.27M

Diluted EPS(ttm)

-3.10

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

-85.71%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

50.14M

Dividend Yield

0.00%

Float4

14.39M

% Held by Insiders

71.10%

% Held by Institutions

86.42%

Balance Sheet

Total Cash(mrq)

171.43M

Total Cash Per Share(mrq)

3.42

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.84%

Quick Ratio(mrq)

14.25%

Book Value Per Share(mrq)

3.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.21

Free Cash Flow(ytd)

-124.64M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement